Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zimmer Holdings (NY:ZBH)

97.97 -0.27 (-0.27%)
Streaming Delayed Price Updated: 12:50 PM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zimmer Holdings

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Accolade, Inc. (Nasdaq - ACCD), Paragon 28, Inc. (NYSE - FNA), Logility Supply Chain Solutions, Inc. (Nasdaq - LGTY), Enfusion, Inc. (NYSE - ENFN)
From Brodsky & Smith LLC
Via GlobeNewswire
Zimmer Biomet Holdings Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
 
Via Benzinga
Zimmer Biomet (NYSE:ZBH) Posts Q4 Sales In Line With Estimates
Medical device company Zimmer Biomet (NYSE:ZBH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.3% year on year to $2.02 billion. Its non-GAAP profit of $2.31 per share was 0.8%... 
Via StockStory
Topics Artificial Intelligence Economy
Earnings Scheduled For February 6, 2025
 
Via Benzinga
Beyond The Numbers: 7 Analysts Discuss Zimmer Biomet Holdings Stock
 
Via Benzinga
What 21 Analyst Ratings Have To Say About Zimmer Biomet Holdings
 
Via Benzinga
(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
 
Via Benzinga
Stocks Edge Higher, Bank Giants Rally, Palantir Skyrockets: What's Driving Markets Thursday?
It's a mixed session on Wall Street, with major indices struggling for direction as investors hold their breath ahead of a key jobs report set for Friday morning. The S&P 500 and the Nasdaq 100 edged... 
Via Benzinga
Topics Stocks
Why Is Zimmer Biomet Stock Trading Lower On Thursday?
Zimmer Biomet beat Q4 estimates with $2.02 billion in sales and $2.31 EPS. 
Via Benzinga
Analyst Expectations For Zimmer Biomet Holdings's Future
 
Via Benzinga
Looking Into Zimmer Biomet Holdings's Recent Short Interest
 
Via Benzinga
Navigating 14 Analyst Ratings For Zimmer Biomet Holdings
 
Via Benzinga
Zimmer Biomet (ZBH) To Report Earnings Tomorrow: Here Is What To Expect
Medical device company Zimmer Biomet (NYSE:ZBH) will be reporting earnings tomorrow before market hours. Here’s what investors should know. 
Via StockStory
Zimmer Biomet Snaps Up Paragon 28 In $1.2 Billion Deal: Details
Zimmer Biomet agrees to acquire Paragon 28 for $1.1 billion, with a non-tradeable CVR up to $1 per share. Deal expected to close in first half of 2025. 
Via Benzinga
Intuitive Surgical Leads the Pack in Robotic Surgery Innovation
The robotic-assisted surgery trend is accelerating and Intuitive Surgical continues to lead the pack as its continued to keeps its wide moat since 2000. 
Via MarketBeat
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
 
Via Benzinga
2 Robotic Surgery Stocks Challenging Intuitive Surgical's Lead
Medtronic (MDT) and Zimmer Biomet (ZBH) are emerging as serious contenders in robotic surgery, challenging Intuitive Surgical’s (ISRG) market dominance. 
Via MarketBeat
Assessing Zimmer Biomet Holdings: Insights From 8 Financial Analysts
 
Via Benzinga
13 Healthcare Sector Stocks With Healthy Valuation
We are looking for value in the Healthcare Sector because we are still in a strong bull market that has been not only one of the longest on record, but also has seen the S&P 500 get to one of its lofty... 
Via Talk Markets
Topics Stocks Stocks / Equities
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
Zimmer Biomet's sales are up 4% to $1.82 billion. Knee and hip products grew, while 2024 EPS guidance was slightly lowered. 
Via Benzinga
McDonald's To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks
The FDA has issued a warning about the increased risk of thigh bone fractures associated with Zimmer Biomet's CPT Hip System. 
Via Benzinga
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs. 
Via MarketBeat
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
 
Via Benzinga
Zimmer Biomet Hammered, Sales Expected To Take A Surprise 1% Hit
The company is well known for its hip and knee replacements. Full-year sales will take an unexpected hit. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia 
Via MarketBeat
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q2 2024
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Medical Technology Stock Benefits from Rising Acute Care Demand
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry. 
Via MarketBeat
Topics Supply Chain
Why Intuitive Surgical Stock is Dominating the Medical Sector
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However 
Via MarketBeat
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.